Compare HAE & TDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HAE | TDS |
|---|---|---|
| Founded | 1971 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.1B |
| IPO Year | 1996 | 1997 |
| Metric | HAE | TDS |
|---|---|---|
| Price | $119.47 | $34.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | ★ $111.50 | $47.50 |
| AVG Volume (30 Days) | 472.9K | ★ 1.4M |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | ★ 0.45% |
| EPS Growth | N/A | ★ 23.53 |
| EPS | 0.72 | ★ 3.50 |
| Revenue | $910,373,000.00 | ★ $1,228,207,000.00 |
| Revenue This Year | $6.21 | $1.06 |
| Revenue Next Year | $5.54 | $1.02 |
| P/E Ratio | $141.61 | ★ $10.13 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $48.17 | $31.51 |
| 52 Week High | $110.45 | $49.12 |
| Indicator | HAE | TDS |
|---|---|---|
| Relative Strength Index (RSI) | 75.86 | 39.94 |
| Support Level | $72.93 | $33.13 |
| Resistance Level | N/A | $35.13 |
| Average True Range (ATR) | 2.90 | 1.07 |
| MACD | 0.07 | -0.22 |
| Stochastic Oscillator | 91.67 | 15.84 |
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The Plasma segment includes end-to-end collection technologies, automated plasmapheresis systems (such as the NexSys PCS device), and donor management software designed for commercial plasma collectors. Hospital segment includes Blood Management Technologies (hemostasis analyzers, cell salvage systems) and Interventional Technologies. And the Blood Center provides solutions and devices enabling blood centers to harvest essential components like platelets and red blood cells.
Telephone and Data Systems Inc is a diversified telecommunications operator that provides communications services to customers through broadband, video, voice, and wireless connections. The company has two reportable segments: TDS Telecom and Array. The majority of its revenue is generated from the TDS Telecom segment, which generates revenue by providing broadband, video, voice, and wireless services. The Array segment generates its revenue mainly by leasing tower space on Array-owned towers to customers.